Pai.ACT: AI-Driven ACT Chatbot for Mental Health Triage and Service Evaluation
NCT06808555
Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder with Hyperactivity
View Trial DetailsNCT Number: NCT06836115
Dyslexia is a common neurodevelopmental condition, which manifests itself in the form of reading difficulties and occurs in 7-10% of the population (Peterson & Pennington, 2012).
As for dyslexia, it is one of the most common learning disorders and the most common cause of difficulties with reading, writing, and spelling. The global prevalence of dyslexia is estimated to be between 5% and 10% of the population, but it may be as high as 17% (Sprenger-Charolles et al., 2011). Stuttering is a speech disorder characterized by involuntary, audible, or silent repetitions or prolongations of sounds or syllables, along with disturbances in the fluency of verbal phrases.Stuttering and dyslexia are two processing deficits that have an impact on a person's social and academic lives, especially as they usually affect the pediatric population more than adults. Even though they affect different domains, they have similar characteristics in their pathogenesis, epidemiology, and impact on life (Algaidy et al., 2023). The aim of the study will be to identify the prevelance of dyslexia in developmental stuttering.
Trial opening soon.
Get Notified9 year–10 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline
arabic reading test in scores
Contact information is provided by the study sponsor or research team.
Wafaa Helmy Abdelhakeem
Other
Reading Problems and Stuttering
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06808555
Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder with Hyperactivity
View Trial DetailsNCT06479850
ADHD, Attention Deficit Disorder with Hyperactivity
View Trial DetailsNCT07459803
Communication Disorders, Dyslexia
Boston, Massachusetts, United States
View Trial DetailsNCT07707700
Communication Disorders, Dyslexia
Hong Kong
View Trial Details